Dimensional Fund Advisors
OLMA icon

Dimensional Fund Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Dimensional Fund Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7M Buy
1,416,533
+334,099
+31% +$4.48M ﹤0.01% 2096
2026
Q1 		$16.1M Buy
1,082,434
+123,790
+13% +$2.76M ﹤0.01% 2069
2025
Q4 		$24M Sell
958,644
-105,905
-10% -$1.88M 0.01% 1886
2025
Q3 		$10.4M Sell
1,064,549
-142,601
-12% -$856K ﹤0.01% 2288
2025
Q2 		$5.14M Sell
1,207,150
-112,029
-8% -$499K ﹤0.01% 2512
2025
Q1 		$4.96M Sell
1,319,179
-13,613
-1% -$68.5K ﹤0.01% 2499
2024
Q4 		$7.77M Sell
1,332,792
-44,132
-3% -$441K ﹤0.01% 2402
2024
Q3 		$16.4M Sell
1,376,924
-308,000
-18% -$3.94M ﹤0.01% 2095
2024
Q2 		$18.2M Sell
1,684,924
-251,233
-13% -$2.72M ﹤0.01% 2002
2024
Q1 		$21.9M Buy
1,936,157
+220,737
+13% +$2.85M 0.01% 1935
2023
Q4 		$24.1M Buy
1,715,420
+21,420
+1% +$288K 0.01% 1892
2023
Q3 		$20.9M Buy
1,694,000
+91,444
+6% +$932K 0.01% 1895
2023
Q2 		$14.5M Buy
1,602,556
+1,389,244
+651% +$8.39M ﹤0.01% 2086
2023
Q1 		$740K Buy
+213,312
New +$870K ﹤0.01% 2964
2022
Q3 		$245K Buy
+88,789
New +$377K ﹤0.01% 3200

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Dimensional Fund Advisors's OLMA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Olema Pharmaceuticals (OLMA) stake by 31% in Q2 2026, buying an estimated $4.48M and bringing the position to 1,416,533 shares worth $17.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Dimensional Fund Advisors first reported a position in OLMA in Q3 2022 and has held it in 15 quarters since. The position peaked at $24.1M in Q4 2023. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Dimensional Fund Advisors held 1,416,533 shares of Olema Pharmaceuticals worth $17.7M as of Q2 2026.
  • Dimensional Fund Advisors bought 334,099 Olema Pharmaceuticals shares in Q2 2026, an estimated $4.48M.
  • Olema Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2096 holding.
  • Dimensional Fund Advisors first reported a position in Olema Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's Olema Pharmaceuticals position peaked at $24.1M in Q4 2023.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.